Anteis is a company focused on innovation, which drives its strong growth and hence devotes a substantial share of its revenue to R&D (equivalent to 11% in 2011). The Research and Development department brings together a multidisciplinary team made up of chemists, biochemists and physicists working in numerous laboratories focused on: chemical transformation and formulation of biopolymers, physical-chemical and microbiological characterization of prototypes, optimization of manufacturing processes, and design and improvement of injection devices.

Since 2005, Anteis has been constantly developing and launching products for the aesthetic dermatology market and it founded, in 2007, its own academy (InjectNow Academy) that enables practitioners, whatever their profile, unique opportunities to improve their level of expertise. Anteis has developed four totally complementary product ranges that permit practitioners to smooth, fill, model and rehydrate the dermis to perfection.

In 2007, the Anteis group created its Ophthalmology department, focusing on applications and devices designed to meet the requirements of this medical-surgical speciality. The Anteis policy is twofold: (i) developing viscoelastic products (OVD) adapted to different eye surgery programs and (ii) designing devices capable of treating major pathologies of the eye’s anterior segment. In the beginning of next year, Anteis will launch a drainage viscoelsatic injectable implant, presented in a glass syringe, indicated as an adjuvant during perforating and non-perforating glaucoma surgery.

It new flag product, Synolis V-A, is an innovative, new-generation treatment for osteoarthritis that provides rapid pain relief. The treatment consists of 3 injections administered over 3 weeks. It shows excellent safety and tolerability. Osteoarthritis, also known as degenerative arthritis, is a painful and potentially immobilizing condition caused by the degeneration and loss of cartilage in one or more joints.

Website: www.anteis.com

Since 2004, venturelab, as national program financed by the Commission for Technology and Innovation CTI, offers custom-tailored training modules to help increase awareness of students for entrepreneurship, as well as individual coaching measures for high-tech start-ups, jointly with numerous partners, in particular universities and engineering schools, and their respective technology transfer offices.

Venturelab training modules place particular emphasis on the project and on practice. The courses are free of charge but admission is selective: successful applicants must have an innovative business idea and demonstrate the will to carry out their project from start to finish.

Our courses at a glance:

• Venture ideas – Discover entrepreneurship: These events take place regularly on your local engineering school, university and school of applied science campuses. Conferences last approximately two hours and are followed by snacks and beverages, ideal for making interesting contacts. Discuss your ideas here and dive into the fascinating world of entrepreneurship.
• Venture challenge – Develop convincing business ideas: If you study, teach or are involved in research in an engineering school, university or school of applied sciences and have an innovative business idea or simply the desire to develop your entrepreneurial skills, this course if for you. Take part in our semester-long education program and you will be surprised at how much you can benefit from working in small groups, and of the amount of know-how you can acquire from our experts.
• Venture plan – Convince your future investors: Is your business idea innovative and technology-based? Have set yourself ambitious goals, do you wish to create a strong business team and conquer international markets? With the venture plan module, you will acquire the tools and knowledge you need to develop a successful strategy and translation your personal vision and innovative business idea into a clear business model and convincing strategy.
• Venture training – Seize your market: Are you ready to go to the next level with your company? Are you looking to conquer international markets? With our venture training module, we will help you adjust your business model to meet your new objectives. During the module, you will have the chance to develop your strategies by working in small peer groups and receive guidance and valuable feedback from our experts. At the end of this five-day workshop, you will present your project in front of a jury of investors and CTI Start-up experts, being eligible for the CTI Start-up label, a quality label on financial markets.
• Venture leaders – the Swiss national entrepreneur team: Do you have what it takes to be part of the elite? If so, then you may have the unique chance of traveling with other top start-ups to Boston (USA) as part of the official Swiss national entrepreneur team. During this time, you will have the opportunity of following an intensive ten-day business development course, and meet successful American start-ups, venture capitalists and start-up experts. Included in this program is a four-day entrepreneurship course offered by Babson College, renowned for dispensing top-level know-how on this subject.

Website: www.venturelab.ch

Our microscopy substrates are used in several laboratories around the world and the fields of use range from chemistry and physics to molecular biology. The palette of our products consists of crystalline gold thin films on mica and on different glass types, and ferroelectric thin films.

Website: www.phasis.ch

Website: www.manep.ch

Our software package uniquely encapsulates hard and soft skills in proprietary matching algorithms and techniques. Its architecture is such that it can easily interoperate with legacy or bespoke in-house solutions.

Our product allows recruiters to find the needle in the haystack, empowers department heads to locate the right resources in their global workforce, and ensures candidates to get a position in line with their aspirations and potential. Our suite provides seamless and rapid talent identification and management though its intuitive and customizable web interface. It also contains the usual metrics recruiters and candidates use in their quests.

For instance, recruiters can elect the appropriate talent search functions for:

• Defining the set of hard and soft skills needed for the position
• Setting the position conditions, like salary range, contract type, and so forth
• Previewing, in real-time, matching results on a proprietary visual matching diagram
• Altering matching function settings for results filtering
• Publishing position(s) to contact or be contacted by the matching candidates

Candidates can fully manage their profile by:

• Listing their hard skills
• Assessing and identifying their soft skills within the platform
• Setting preferences, like corporate environment, minimum salary, and so forth
• Browsing, in real-time, matching openings and opportunities on a visual matching diagram
• Publishing, in confidence or not, their profile and contact information

Our matching engines empower candidates to fully appraise, in confidence, their strengths and weaknesses from perspectives specific to industry needs.

• Department heads can efficiently manage their workforce to suit to their fast evolving needs by:
• Defining the set of hard and soft skills needed for the internal position or project
• Setting the project parameters, like number of people, timeframe, budget, and so forth
• Evaluating available employees on a visual matching diagram
• Identifying Hard and soft skills employees would need to reinforce

Our solution is scalable and suits small, medium and large public, private or governmental entities like global multinationals, unemployment offices or pure recruitment groups and placement agencies.

To schedule a demo of our product and solutions, please contact us at: contact@eldorajob.com

Website: www.eldorajob.com

Founded in 2001, the Company is dedicated to the development of innovative technologies and world-class expert services that significantly reduce the time, effort, and costs associated with developing high-performance mammalian cell lines for therapeutic protein production (e.g. monoclonal antibodies (MAbs), growth factors, enzymes).

The Selexis SUREtechnology Platform™ improves the way cells are used in the discovery, development and manufacturing of recombinant protein drugs by providing key significant advantages over traditional approaches. The SUREtechnology Platform™ is based on Selexis Genetic Elements™ — novel DNA-based elements that control the dynamic organization of chromatin within all mammalian cells and allow for higher and more stable expression of recombinant proteins. The Selexis SUREtechnology Platform™ provides users a single platform that can be used for a wide range of applications from late R&D to biologics manufacturing including target discovery, cell-based assays, protein production for discovery and pre-clinical studies, diagnostics, bio-manufacturing of therapeutic proteins.

As of 4Q2011, Selexis has generated over 1,300 clonal cell lines being used in a variety of programs from discovery to late-stage clinical trials. More than 20 Selexis cell lines are in clinical trials and the Company anticipates several products manufactured from cell lines using the Selexis SUREtechnology Platform™ to be launched in 2012.

Website: www.selexis.com

H3oC was instrumental in designing and managing transnational frameworks and projects, for instance, in:

• Microtechnology and electronics (mind-microtech);
• Defining housing and neighbourhoods that will have sufficient, high quality, sustainable homes within an economically prosperous, green, supportive and cohesive borough (eco-obs).

FONGIT also elected H3oC to:

• Tutor an engineering company to optimize its operations, processes, and market strategy, and value its core technology accordingly;
• Assist the incubator in refining its strategy in green technologies.

H3oC  was also mandated by Swiss, French speaking cantons to determine the viability of a Cleantech cluster in Western Switzerland.  Its report facilitated this network to become the gateway to Cleantech in western Switzerland, as it supports the development of its companies and research organizations, and promotes the region as a European center of excellence for clean technologies (cleantech-alps).

venture kick aims at early identification, structuring and promotion of promising business ideas with a clear vision: to double the number of spin-offs at Swiss universities, to accelerate the founding process and raise the attractiveness of these young companies for professional investors.

GET CHF 130‘000 FOR YOUR START-UP
In order to receive the entire start capital of CHF 130’000, you must prove the potential of your business idea in three phases. Each phase ends with a presentation in front of a highly-qualified panel of investors, entrepreneurs and technology experts. If you are successful in convincing the jury with your pitch, you will receive a grant to help you further develop your business idea and you will benefit from professional guidance.

CHF 10‘000 FOR A BRILLIANT BUSINESS IDEA
Stage 1: You apply with a vision and a clear idea of how you intend to turn your research project into a sustainable business. Applicants with the most exciting business ideas are invited for an interview. Eight projects are selected to present their business ideas – four of the most promising projects enter the support process.

CHF 20‘000 FOR A SOLID BUSINESS CASE
Stage 2: During three months, you will have the time to structure your business idea, target initial customers and strategic partners, collect feedback and work out a convincing investor presentation. You will then present your project again to a panel of experts. Only two projects out of the four pass on to the next phase.

CHF 100‘000 FOR YOUR SUCCESSFUL START-UP
Stage 3: Six months later you are ready for the market. You have written a convincing business plan, formed a team and secured your intellectual property. Now all that remains to be done is to convince a panel of experts and investors. If you are successful, you will win CHF 100’000 for your company.

CONDITIONS OF PARTICIPATION
The program is open to individuals having a business idea and currently enrolled in a Swiss academic institution (student, PhD student, post-doc, assistant or professors etc.), in any scientific field, and who wish to start their company in Switzerland. Also, applicants must not have already received any venture capital.

Apply here !

The FloWatch-PAB uses patented wireless technology to send instructions, receive feedback and adjust the implanted device, therefore the implanted device does not contain a battery, all power coming from the signal.

We are actively investigating other indications for the FloWatch-PAB, and the development of the technology for current and other medical uses. This will be with in-house resources and in partnership with others.

LemanMedical will establish it’s own clean production facility (ISO-7 Class-10,000) during the first half of 2012, to-date production has been subcontracted. We will also have facilities for development and testing.

The FW-PAB is approved in many European and Middle-East countries and LemanMedical is active in expanding further.

The FloWatch-PAB has several proven clinical and financial advantages including:

• Accurate and repeatable wireless adjustment
• Ease of implantation and removal
• Elimination of need for reconstructive surgery on band removal
• Significant reduction in post-operative mechanical ventilation and ICU &  hospital stay
• Improved mortality rates

Website: www.lemanmedical.com